COVID-19 in the municipalities of Botucatu and Serrana, São Paulo, Brazil, the effects of lethality and mortality
DOI:
https://doi.org/10.36311/jhgd.v32.13255Keywords:
COVID-19, SARS-CoV-2, mort, lethality, Epidemiology, quarantineAbstract
Introduction: in 2019, the proliferation of a virus identified as SARS-CoV-2 emerged in the city of Wuhan, a district in China, quickly spread throughout the world, gaining pandemic status and less than 1 year, its repercussions and magnitude caused scientists, governments and society to adopt severe measures to combat this disease.
Objective: to analyze mortality, incidence and mortality from COVID-19 in the municipalities of Botucatu and Serrana, São Paulo, Brazil.
Methods: this is an ecological study with a time series design with secondary data. All registered cases and deaths registered by COVID-19 from April 2020 to August 2021 in the municipalities of Botucatu and Serrana, São Paulo, Brazil were considered. The incidence, mortality and lethality rate were used. The monthly and/or weekly percentage variation and their respective 95% confidence intervals were estimated.
Results: it identified that 12.88% of the residents of the city of Botucatu were infected with COVID-19 and 8.61% of the population of the municipality of Serrana was infected. There was a stationary trend of mortality and incidence in the period between April 2020 and May 2021 and decreasing in both sexes in the mortality rate in the municipality of Serrana, in the city of Botucatu there was a trend of increasing mortality and incidence in the same period observed.
Conclusion: The mass vaccination strategy of citizens in the cities of Botucatu and Serrana present robust data to consider that immunization has a decreasing effect on the number of cases and deaths from COVID-19, which effectively contributes to fighting the pandemic and reduces the contamination and progression of the disease to more severe cases.
Downloads
References
World Health Organization. WHO declares COVID-19 as a global pandemic. 2020 Available at: https://www.who.int/dg/speeches/detail/who-director-general-sopening- remarks-at%20-the-media-briefing-on-covid-19—11-march-2020. Accessed on may 25, 2021
Vandenberg O, et al. “Considerations for diagnostic COVID-19 tests.” Nature Reviews Microbiology (2020): 1-13.
WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: [june 04 2021]).
Abreu LC. The path of humanity in the pandemic of COVID -19: the choice of the realistic, optimist or pessimist scenario. J Hum Growth Dev. 2021; 31(1):05-08. DOI: 10.36311/jhgd.v31.11683
Counts, Global, et al. “COVID Data Tracker.” (2021). CDC COVID Data Tracker
WHO. Coronavirus disease (COVID-19) advice for the public: When and how to use masks. 2021. Access: When and how to use masks (who.int)
Do portal do Governo. Governo de São Paulo. SP contra o novo coronavírus. 2021. access: (https://www.saopaulo.sp.gov.br/coronavirus/
Reuters. Áustria anuncia lockdown total e tornará vacinação contra Covid-19 obrigatória. Internacional. 2021. Access: https://www.cnnbrasil.com.br/internacional/austria-anuncia-lockdown-total-e-tornara-vacinacao-contra-covid-19-obrigatoria/
Brasil. Ministerio da saude. COVID-19 doses de vacinação aplicadas. 2021.Acess: https://infoms.saude.gov.br/extensions/DEMAS_C19_Vacina_v2/DEMAS_C19_Vacina_v2.html
Yunis M. UNICEF on What It’s Like to Be a Child in Today’s World. GALLUP. News 2021; access: https://news.gallup.com/podcast/357542/unicef-child-today-world.aspx
Butantan. Projeto S: imunização em Serrana faz casos de Covid-19 despencarem 80% e mortes, 95%. Disponível em: <https://butantan.gov.br/noticias/projeto-s-imunizacao-em-serrana-faz-casos-de-covid-19-despencarem-80-e-mortes-95> Acesso: 04 jun. 2021.
Palácios R, Patiño EG, Piorelli RDO, Conde MTRP, Batista AP, Zeng G, et al. Double-Blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac – PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct; 21:853. doi:10.1186/s13063-020-04775-4.
Cruz, EP. Covid-19: vacinação em massa tem resultados positivos em Botucatu. Saúde. Agencia Brasil. 2021. https://agenciabrasil.ebc.com.br/saude/noticia/2021-08/vacinacao-em-massa-apresenta-resultados-positivos-no-interior-paulista
Fava-de-Moraes F, Martinez Soto MJDC. Informação e Conhecimento no Setor Público: a experiência da Fundação SEADE. São Paulo em Perspectiva. 2002; 16 (3):15-22.
Antunes JLF, Cardoso MRA. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol. Serv. Saúde. 2015; 24 (3): 565-576.
Coronavírus Brasil. Painel. https://covid.saude.gov.br/. 2021.
WHO. Imunization. 2019. Access: https://www.who.int/news-room/facts-in-pictures/detail/immunization#:~:text=Immunization%20prevents%20deaths%20every%20year,cost%2Deffective%20public%20health%20interventions ( 2020 )
Covian C, Retamal-Diaz A, Bueno SM, Kalergis AM. A vacinação BCG pode induzir imunidade protetora treinada para SARS-CoV-2? Frente. Immunol. 2020; 11: 970.
Voloch CM, et al. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. Journal of Virology, 2021.
Case JB, Winkler ES, Errico JM, Diamond MS. On the road to ending the COVID-19 pandemic: Are we there yet?, Virology. 2021; 557: 70-85. https://doi.org/10.1016/j.virol.2021.02.003.
Kanno AI, Barbosa MMF, Moraes L, Leite LCC. SARS-CoV-2 vaccine development and how Brazil is contributing. Genet Mol Biol. 2021 Mar 29;44(1 Suppl 1):e20200320. doi: 10.1590/1678-4685-GMB-2020-0320.
Domingues CMAS, et al. Programa Nacional de Imunização: a política de introdução de novas vacinas. Revista Eletrônica Gestão e Saúde. 2015; 4: 3250-3274.
Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Feb;21(2):181-192.
Palácios R, Patiño EG, Piorelli RDO, Conde MTRP, Batista AP, Zeng G, et al. Double-Blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac – PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct; 21:853. doi:10.1186/s13063-020-04775-4.
Federal, conselho; do Brasil-cfoab, advogados; scaletsky, felipe de santa cruz oliveira. Arguição de descumprimento de preceito fundamental 672 distrito federal. Decisão do Ministro Relator Lewandowski. Brasília, v. 3.
O. B. AHMAD, AGE STANDARDIZATION OF RATES: A NEW WHO STANDAR. GPE Discussion Paper Series; EIP/GPE/EBD. World Health Organization. 2001; (31).
WHO. Coronavirus disease (COVID-19) advice for the public: Mythbusters. 2021. Access: Mythbusters (who.int)
Lima NT, Buss PM, Paes-Sousa R. A pandemia de COVID-19: uma crise sanitária e humanitária. Cadernos de Saúde Pública. 2020; 36 (7): 1-4.
Bezerra IMP. State of the art of nursing education and the challenges to use remote technologies in the time of corona virus pandemic. J Hum Growth Dev. 2020; 30(1):141-147.
Pimentel RMM, et al. The dissemination of COVID-19: an expectant and preventive role in global health. Journal of Human Growth and Development, 2020; 30 (1): 135-140.
Do Portal do Governo. Governo de SP adota fase emergencial para conter crescimento de pandemia. Disponível em: https://www.saopaulo.sp.gov.br/noticias-coronavirus/governo-de-sp-adota-fase-emergencial-para-conter-crescimento-de-pandemia-2/. 11 de março de 2021. Acesso: 10 de abril de 2021.
Vandormael A, et al. Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach. International Journal of Epidemiology. 2018; 47(1): 236-245.
Antunes JLF, Cardoso MRA. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol. Serv. Saúde. 2015; 24(3): 565-576.
Bermudi PMM, et al. Spatiotemporal ecological study of COVID-19 mortality in the city of São Paulo, Brazil: shifting of the high mortality risk from areas with the best to those with the worst socio-economic conditions. Travel medicine and infectious disease. 2021; 39: 101945.
Verma P, et al. A Statistical Analysis of Impact of COVID19 on the Global Economy and Stock Index Returns. SN Computer Science. 2021; 2(1): 1-13.
Abbott S, et al. National and Subnational estimates for Brazil, 2020. Disponível em: https://epiforecasts.io/covid/posts/national/brazil/. Acesso 1 de abril de 2021.
Pilar AF. InfoGripe indica estabilidade na incidência de SRAG no Brasil. Canal Saúde – FioCruz.2021. Access: https://www.canalsaude.fiocruz.br/noticias/noticiaAberta/infogripe-indica-estabilidade-na-incidencia-de-srag-no-brasil19112021
Valenti VE, Silva AP. The effect of negationism on public health. J Hum Growth Dev. 2021; 31(2):189-191. DOI: 10.36311/jhgd.v31.12299
Abreu LC. The path of humanity in the pandemic of COVID-19: the choice of the realistic, optimist or pessimist scenario. J Hum Growth Dev. 2021; 31(1):05-08. DOI: 10.36311/jhgd.v31.11683
OMS.OPAS. Investimento na atenção primária à saúde é urgente para garantir recuperação da COVID-19 nas Américas. 2021. Access: https://www.paho.org/pt/noticias/10-11-2021-investimento-na-atencao-primaria-saude-e-urgente-para-garantir-recuperacao-da
Castro R. Alerta europeu demonstra que Covid-19 ainda é um desafio. Canal Saúde- FioCruz. 2021. Access: https://www.canalsaude.fiocruz.br/noticias/noticiaAberta/alerta-europeu-demonstra-que-covid-19-ainda-e-um-desafio18112021
Valente J. Covid-19: Brasil acumula 21.989.962 de casos e 612.144 mortes. Até o momento, 297,9 milhões de doses de vacinas contra a covid-19 foram aplicadas. Canal Saúde- FioCruz. 2021. Access: https://www.canalsaude.fiocruz.br/noticias/noticiaAberta/covid-19-brasil-acumula-21989962-de-casos-e-612144-mortes-ate-o-momento-2979-milhoes-de-doses-de-vacinas-contra-a-covid-19-foram-aplicadas19112021
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Silva AP, Ribeiro MA, Emídio MP, Daboin BEG, Morais TC, de Oliveira Abreu CIP, Bezerra IMP, Abreu LC
This work is licensed under a Creative Commons Attribution 4.0 International License.
